These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 18771658

  • 1. The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis.
    Kim EH, Surh YJ.
    Biochem Pharmacol; 2008 Dec 01; 76(11):1544-53. PubMed ID: 18771658
    [Abstract] [Full Text] [Related]

  • 2. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
    Kim EH, Surh YJ.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1516-28. PubMed ID: 16987499
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
    Kondoh K, Tsuji N, Asanuma K, Kobayashi D, Watanabe N.
    Exp Cell Res; 2007 Oct 01; 313(16):3486-96. PubMed ID: 17706193
    [Abstract] [Full Text] [Related]

  • 4. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD.
    Mol Pharmacol; 2005 Jul 01; 68(1):169-78. PubMed ID: 15821150
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
    Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M.
    Mol Pharmacol; 2007 Nov 01; 72(5):1246-57. PubMed ID: 17673570
    [Abstract] [Full Text] [Related]

  • 6. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.
    Napimoga MH, Souza GR, Cunha TM, Ferrari LF, Clemente-Napimoga JT, Parada CA, Verri WA, Cunha FQ, Ferreira SH.
    J Pharmacol Exp Ther; 2008 Jan 01; 324(1):313-21. PubMed ID: 17928570
    [Abstract] [Full Text] [Related]

  • 7. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
    Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D.
    Mol Pharmacol; 2004 Nov 01; 66(5):1349-58. PubMed ID: 15317873
    [Abstract] [Full Text] [Related]

  • 8. High-performance affinity purification for identification of 15-deoxy-Δ 12,14 -PGJ₂ interacting factors using magnetic nanobeads.
    Maekawa N, Hiramoto M, Sakamoto S, Azuma M, Ito T, Ikeda M, Naitou M, Acharya HP, Kobayashi Y, Suematsu M, Handa H, Imai T.
    Biomed Chromatogr; 2011 Apr 01; 25(4):466-71. PubMed ID: 21374648
    [Abstract] [Full Text] [Related]

  • 9. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
    Ueki S, Kato H, Kobayashi Y, Ito W, Adachi T, Nagase H, Ohta K, Kayaba H, Chihara J.
    Int Arch Allergy Immunol; 2007 Apr 01; 143 Suppl 1():15-22. PubMed ID: 17541271
    [Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510.
    Huang H, Campbell SC, Bedford DF, Nelius T, Veliceasa D, Shroff EH, Henkin J, Schneider A, Bouck N, Volpert OV.
    Mol Cancer Res; 2004 Oct 01; 2(10):541-50. PubMed ID: 15498928
    [Abstract] [Full Text] [Related]

  • 11. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism.
    Olmos G, Conde I, Arenas I, Del Peso L, Castellanos C, Landazuri MO, Lucio-Cazana J.
    Cell Signal; 2007 Oct 01; 19(10):2098-105. PubMed ID: 17658243
    [Abstract] [Full Text] [Related]

  • 12. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
    Emi M, Maeyama K.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1259-67. PubMed ID: 15013841
    [Abstract] [Full Text] [Related]

  • 13. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
    Genovese T, Esposito E, Mazzon E, Di Paola R, Muià C, Meli R, Bramanti P, Cuzzocrea S.
    Shock; 2008 Aug 01; 30(2):142-52. PubMed ID: 18628687
    [Abstract] [Full Text] [Related]

  • 14. 15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction.
    Hwang J, Lee HI, Chang YS, Lee SJ, Kim KP, Park SI.
    Biochem Biophys Res Commun; 2007 May 25; 357(1):206-11. PubMed ID: 17418102
    [Abstract] [Full Text] [Related]

  • 15. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW, Seo CY, Han H, Han JY, Jeong JS, Kwak JY, Park JI.
    Clin Cancer Res; 2009 Sep 01; 15(17):5414-25. PubMed ID: 19690198
    [Abstract] [Full Text] [Related]

  • 16. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
    Zhang M, Deng C, Zheng J, Xia J, Sheng D.
    Int Immunopharmacol; 2006 Aug 01; 6(8):1233-42. PubMed ID: 16782535
    [Abstract] [Full Text] [Related]

  • 17. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
    Coyle AT, O'Keeffe MB, Kinsella BT.
    FEBS J; 2005 Sep 01; 272(18):4754-73. PubMed ID: 16156795
    [Abstract] [Full Text] [Related]

  • 18. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state.
    Katura T, Moriya T, Nakahata N.
    Mol Pharmacol; 2010 Apr 01; 77(4):601-11. PubMed ID: 20086036
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1.
    Fu YG, Sung JJ, Wu KC, Bai AH, Chan MC, Yu J, Fan DM, Leung WK.
    Cancer Lett; 2006 Nov 18; 243(2):246-54. PubMed ID: 16412567
    [Abstract] [Full Text] [Related]

  • 20. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells.
    Suk FM, Chen CH, Lin SY, Cheng CJ, Yen SJ, Hung LF, Liu DZ, Liang YC.
    Toxicol Lett; 2009 May 22; 187(1):22-7. PubMed ID: 19429239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.